Speaking at the NHS Confederation’s annual conference in Liverpool on Wednesday 4 June, Stevens said that the NHS “should be rigorously pro-research” and suggested that such an approach could enable the NHS to become a world leader in health service innovation.
The NHS had a poor record of evaluating service changes, he told delegates. The service now needed to “accelerate the redesign of care delivery” through “some well controlled experimentation.” He explained, …
Similarly, the Royal College of Pathologists has been duped into thinking management tools are different from medical treatments and may not present risks to patients, staff or finances. UKAS reports that the College has made its Chief Executive an honorary Fellow:
UKAS is becoming increasingly active in the Healthcare sector. The influence and use of UKAS accreditation in healthcare continues to grow across a wide range of areas, to support the delivery of informed and effective purchasing, good governance and public confidence. UKAS accreditation assesses against internationally recognised standards, raises the level of competency, and enhances the credibility of the service amongst patients, professionals and commissioners, providing assurance to those who fund the services. It also brings national recognition to the service, with a badge of quality.As part of this growing recognition, The Royal College of Pathologists (RCPath) has made Paul Stennett, Chief Executive of Clinical Pathology Accreditation (CPA) and UKAS, an Honorary Fellow. The award has been given in recognition of Mr Stennett’s contribution to the modernisation of accreditation of pathology services in the UK, including the transition to the international ISO 15189:2012 standard for medical laboratories. Honorary Fellowshipis awarded to persons, whether medically qualified or not, who have made notable contributions to pathology, or who have shown distinction of a nature fit to be recognised by the Royal College.Paul Stennett was appointed Chief Executive ofUKAS in 2003 and he has encouraged an innovative approach to the use of accreditation in a number of new areas, particularly the health care sector. In 2009 CPA became a wholly owned subsidiary of UKAS, marking a significant step in a decade long working relationship between the two companies. In 2013 he oversaw commencement of the transition project which will see all CPA accredited organisations move to the new ISO 15189 standard by the end of 2017.Mr Stennett said: “I feel greatly honoured and delighted to receive this award in recognition of the sterling work carried out by staff at all levels within both CPA and UKAS in support of accreditation in medical laboratories. I am also grateful to RCPath for its on-going and invaluable support in helping to create a leading, globally acknowledged and respected pathology accreditation process. The award reflects the increased recognition of the role that accreditation is playing in supporting medical laboratories to deliver a safe, reliable and effective service for patients.”
If the Royal Colleges and their Academy want to enter the debate, they should do so using rigorous science. This implies the need to explore more fully the benefits and disutilities of service reconfiguration, rather than simply claiming that change is justified on the basis of studies of single conditions with significant P values.
UKAS, however, has no P values. The organisation is exempt from measuring the uncertainty of its work in the way it requires of those who pay its fees.